日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08)

NISCAHN:一项针对唾液腺癌患者的纳武利尤单抗 II 期试验(Unicancer ORL-08)

Fayette, Jérôme; Even, Caroline; Digue, Laurence; Geoffrois, Lionnel; Rolland, Fréderic; Cupissol, Didier; Guigay, Joel; Le Tourneau, Christophe; Dillies, Anne Françoise; Zanetta, Sylvie; Bozec, Laurence; Borel, Christian; Couchon-Thaunat, Sophie; Costes-Martineau, Valérie; Sudaka-Bahadoran, Anne; Jallut, Isabelle; Garic, Florence; Lardy-Cleaud, Audrey; Chabaud, Sylvie

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

曲贝替定诱导晚期软组织肉瘤患者严重肝毒性的药物遗传学研究

Maillard, Maud; Chevreau, Christine; Le Louedec, Félicien; Cassou, Manon; Delmas, Caroline; Gourdain, Laure; Blay, Jean-Yves; Cupissol, Didier; Bompas, Emmanuelle; Italiano, Antoine; Isambert, Nicolas; Delcambre-Lair, Corinne; Penel, Nicolas; Bertucci, François; Guillemet, Cécile; Plenecassagnes, Julien; Foulon, Stéphanie; Chatelut, Étienne; Le Cesne, Axel; Thomas, Fabienne

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.

西妥昔单抗在晚期头颈癌患者中的药代动力学/药效学关系

Le Louedec Félicien, Alix-Panabières Catherine, Lafont Thierry, Allal Ben C, Garrel Renaud, Digue Laurence, Guigay Joël, Cupissol Didier, Delord Jean-Pierre, Lallemant Benjamin, Alfonsi Marc, Aubry Karine, Mazel Martine, Becher François, Perriard Françoise, Chatelut Etienne, Thomas Fabienne

The off-label use of targeted therapies in sarcomas: the OUTC'S program

肉瘤靶向治疗的超适应症使用:OUTC 计划

Eberst, Lauriane; Cropet, Claire; Le Cesne, Axel; Pautier, Patricia; Penel, Nicolas; Adenis, Antoine; Chevreau, Christine; Bay, Jacques-Olivier; Collard, Olivier; Cupissol, Didier; Duffaud, Florence; Gentet, Jean-Claude; Piperno-Neumann, Sophie; Marec-Berard, Perrine; Bompas, Emmanuelle; Thyss, Antoine; Chaigneau, Loic; Cassier, Philippe; Bertucci, François; Blay, Jean-Yves; Ray-Coquard, Isabelle

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO)

索拉非尼治疗晚期血管肉瘤患者:法国肉瘤研究组 (GSF/GETO) 的 II 期试验

Ray-Coquard, Isabelle; Italiano, Antoine; Bompas, Emmanuelle; Le Cesne, Axel; Robin, Yves-Marie; Chevreau, Christine; Bay, Jacques-Olivier; Bousquet, Guilhem; Piperno-Neumann, Sophie; Isambert, Nicolas; Lemaitre, Laurent; Fournier, Charles; Gauthier, Eric; Collard, Olivier; Cupissol, Didier; Clisant, Stéphanie; Blay, Jean-Yves; Penel, Nicolas

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

吉西他滨单药治疗与吉西他滨联合多西他赛治疗转移性或复发性平滑肌肉瘤患者的随机多中心分层 II 期研究:法国国家癌症中心联盟 (FNCLCC) 法国肉瘤组研究 (TAXOGEM 研究)

Pautier, Patricia; Floquet, Anne; Penel, Nicolas; Piperno-Neumann, Sophie; Isambert, Nicolas; Rey, Annie; Bompas, Emmanuelle; Cioffi, Angela; Delcambre, Corinne; Cupissol, Didier; Collin, Françoise; Blay, Jean-Yves; Jimenez, Marta; Duffaud, Florence